|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 16.14 CHF | -0.98% |
|
+3.58% | -14.74% |
| 17/04 | AARDEX Group announced that it has received funding from medmix AG | CI |
| 16/04 | Medmix Unit Enters Japanese Distribution Deal for PiccoJect Product | MT |
medmix AG reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was CHF 477.1 million compared to CHF 457.3 million a year ago. Net income was CHF 11.6 million compared to CHF 44 million a year ago.
Basic earnings per share from continuing operations was CHF 0.28 compared to CHF 1.07 a year ago. Diluted earnings per share from continuing operations was CHF 0.28 compared to CHF 1.07 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -14.74% | 736M | |
| -4.98% | 182B | |
| +2.84% | 112B | |
| -2.68% | 68.58B | |
| +4.53% | 51.58B | |
| +8.00% | 44.24B | |
| +9.45% | 43.65B | |
| +25.30% | 32.46B | |
| +20.94% | 25.99B | |
| -0.17% | 25.61B |
MEDMIX AG 
